NQCCX
Price
$3.96
Change
+$0.04 (+1.02%)
Updated
Jul 3 closing price
Net Assets
23.18M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

NQCCX vs VVIAX

Header iconNQCCX vs VVIAX Comparison
Open Charts NQCCX vs VVIAXBanner chart's image
Nuveen Large Cap Value Opportunities C
Price$3.96
Change+$0.04 (+1.02%)
VolumeN/A
Net Assets23.18M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
NQCCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NQCCX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NQCCX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. NQCCX (23.2M). VVIAX pays higher dividends than NQCCX: VVIAX (2.18) vs NQCCX (1.01). NQCCX was incepted earlier than VVIAX: NQCCX (19 years) vs VVIAX (25 years). NQCCX (2.36) is less costly to investors than VVIAX (0.05). NQCCX is a more actively managed with annual turnover of: 35.00 vs. VVIAX (9.00). NQCCX has a lower initial minimum investment than VVIAX: NQCCX (2500) vs VVIAX (3000). VVIAX (12.03) and NQCCX (11.88) have marching annual gain over last year. VVIAX return over 5 years is better than : 80.13 vs. NQCCX (28.35).
NQCCXVVIAXNQCCX / VVIAX
Total Expense Ratio1.750.053,500%
Annual Report Gross Expense Ratio2.360.054,720%
Fund Existence19 years25 years-
Gain YTD10.9246.198176%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets23.2M189B0%
Annual Yield % from dividends1.012.1846%
Returns for 1 year11.8812.0399%
Returns for 3 years38.7935.17110%
Returns for 5 years28.3580.1335%
Returns for 10 years-63.55115.67-55%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.